Amy Bachrodt, SVP, Finance at Maze Therapeutics, Inc. (MAZE), sold 10,000 shares at $44.44 ($452K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Open-market sale of $452k MAZE by SVP, Finance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.44 | 1,300 | $58K | 12.8% |
| 2 | $44.44 | 1,300 | $58K | 12.8% |
| 3 | $45.47 | 3,700 | $168K | 37.2% |
| 4 | $45.47 | 3,700 | $168K | 37.2% |
| Total | $45.20 avg | 10,000 | $452K | 100% |
| Filing → |
| MAZE | SELL | 2026-01-26 | $455K | — | Filing → |
| MAZE | SELL | 2026-01-06 | $392K | — | Filing → |
| MAZE | SELL | 2025-12-31 | $606K | — | Filing → |